|
May 14
|
Scholar Rock to Host Investor Day on May 22, 2024
|
|
May 7
|
Scholar Rock Holding Corp (SRRK) Reports Q1 2024 Financial Results: A Detailed Analysis
|
|
May 7
|
Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress
|
|
Apr 24
|
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
|
|
Mar 20
|
Scholar Rock Holding Corp Reports Full Year 2023 Financial Results
|
|
Mar 19
|
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress
|
|
Mar 15
|
Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks
|
|
Jan 12
|
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Dec 19
|
Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 10
|
Insider Sell: COO & CFO Edward Myles Sells 24,914 Shares of Scholar Rock Holding Corp (SRRK)
|
|
Nov 7
|
Scholar Rock Holding Corp (SRRK) Reports Q3 2023 Financial Results
|
|
Nov 7
|
Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress
|
|
Nov 6
|
Wall Street Analysts See a 99.11% Upside in Scholar Rock Holding Corporation (SRRK): Can the Stock Really Move This High?
|
|
Nov 4
|
Insider Sell: Edward Myles Sells 35,007 Shares of Scholar Rock Holding Corp (SRRK)
|
|
Nov 3
|
Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability
|
|
Nov 2
|
Scholar Rock to Participate in Upcoming Investor Conferences
|
|
Aug 9
|
Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress
|